Home / AUROPHARMA.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does AUROPHARMA.NS make money? Does AUROPHARMA.NS have pricing power? What's the Earnings Whisper? Will AUROPHARMA.NS profit more as the business scales? What is AUROPHARMA.NS's management track record? Is AUROPHARMA.NS's current price justified?

Aurobindo Pharma Limited

₹1666.9 +$473.90 (+39.72%)

NSE · 16 Oct 2026 09:58 UTC

Previous Close

₹1677.9

Day Range

₹1655₹1681.7

Year Range

₹1080.1₹1740

Market Cap

959.1B

AVG Volume

1.04M

Trailing/Forward PE

26.05/18.28

PEG ratio

0.89

Dividend Yield

Next Earnings Date

2026-11-14

Primary Exchange

National Stock Exchange of India

Revenue (INR) · Q

AUROPHARMA.NS Revenue (INR) by quarter
Period	Revenue (INR)
27 Q1	91.06B
26 Q4	88.53B
26 Q3	86.46B
26 Q2	82.86B
26 Q1	78.68B
25 Q4	83.82B
25 Q3	79.79B
25 Q2	77.96B
25 Q1	75.67B
24 Q4	75.8B

Net Income (INR) · Q

AUROPHARMA.NS Net Income (INR) by quarter
Period	Net Income (INR)
27 Q1	10.33B
26 Q4	9.21B
26 Q3	9.1B
26 Q2	8.48B
26 Q1	8.25B
25 Q4	9.03B
25 Q3	8.46B
25 Q2	8.17B
25 Q1	9.19B
24 Q4	9.09B

Operating Income (INR) · Q

AUROPHARMA.NS Operating Income (INR) by quarter
Period	Operating Income (INR)
27 Q1	13.94B
26 Q4	13.22B
26 Q3	13.09B
26 Q2	12.49B
26 Q1	34B
25 Q4	15.71B
25 Q3	35.32B
25 Q2	34.76B
25 Q1	34.22B
24 Q4	14.67B

EBITDA · Q

Cash Flows · Q

EPS · Q

Expenses · Q

Cash & Debt · Q

Debt ratios · Q

Margins · Q

Return on Capital · Q

Shares Outstanding · Q

Dividends (INR) · Q

Employee Count

Book Value Per Share · Q

Total Assets · Q

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Aurobindo Pharma Limited

Video analysis: AUROPHARMA.NS

News: AUROPHARMA.NS

Similar companies